These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 11429059)

  • 1. Effect of combination therapy with matrix metalloproteinase inhibitor MMI-166 and mitomycin C on the growth and liver metastasis of human colon cancer.
    Ohta M; Konno H; Tanaka T; Baba M; Kamiya K; Oba K; Kaneko T; Syouji T; Igarashi A; Nakamura S
    Jpn J Cancer Res; 2001 Jun; 92(6):688-95. PubMed ID: 11429059
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Augmented anti-metastatic efficacy of a selective matrix metalloproteinase inhibitor, MMI-166, in combination with CPT-11.
    Maki H; Hojo K; Tanaka H; Sawada TY; Maekawa R; Yoshioka T
    Clin Exp Metastasis; 2002; 19(6):519-26. PubMed ID: 12405289
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparison of the inhibitory effect of the angiogenesis inhibitor, TNP-470, and mitomycin C on the growth and liver metastasis of human colon cancer.
    Konno H; Tanaka T; Matsuda I; Kanai T; Maruo Y; Nishino N; Nakamura S; Baba S
    Int J Cancer; 1995 Apr; 61(2):268-71. PubMed ID: 7535757
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of liver metastasis of human colon cancer by selective matrix metalloproteinase inhibitor MMI-166.
    Oba K; Konno H; Tanaka T; Baba M; Kamiya K; Ohta M; Kaneko T; Shouji T; Igarashi A; Nakamura S
    Cancer Lett; 2002 Jan; 175(1):45-51. PubMed ID: 11734335
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination therapy with vascular endothelial growth factor neutralizing antibody and mitomycin C on human gastric cancer xenograft.
    Matsumoto K; Konno H; Tanaka T; Baba M; Kanai T; Kamiya K; Ohba K; Nakamura S
    Jpn J Cancer Res; 2000 Jul; 91(7):748-52. PubMed ID: 10920283
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of in vivo tumor growth by MMI-166, a selective matrix metalloproteinase inhibitor, through inhibition of tumor angiogenesis in squamous cell carcinoma cell lines of head and neck.
    Katori H; Baba Y; Imagawa Y; Nishimura G; Kagesato Y; Takagi E; Ishii A; Yanoma S; Maekawa R; Yoshioka T; Nagashima Y; Kato Y; Tsukuda M
    Cancer Lett; 2002 Apr; 178(2):151-9. PubMed ID: 11867199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of liver metastasis of human gastric carcinoma by angiogenesis inhibitor TNP-470.
    Shishido T; Yasoshima T; Denno R; Sato N; Hirata K
    Jpn J Cancer Res; 1996 Sep; 87(9):958-62. PubMed ID: 8878459
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Effect of anti-vascular endothelial growth factor antibody on the progression of human gastric cancer orthotopic xenotransplanted into nude mice].
    Tao H; Lin Y; Yin H; Yao M
    Zhonghua Wai Ke Za Zhi; 1999 Apr; 37(4):248-50. PubMed ID: 11829834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-metastatic efficacy and safety of MMI-166, a selective matrix metalloproteinase inhibitor.
    Maekawa R; Maki H; Wada T; Yoshida H; Nishida-Nishimoto K; Okamoto H; Matsumoto Y; Tsuzuki H; Yoshioka T
    Clin Exp Metastasis; 2000; 18(1):61-6. PubMed ID: 11206840
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Matrix metalloproteinase inhibitor MMI-166 inhibits lymphogenous metastasis in an orthotopically implanted model of lung cancer.
    Fujino H; Kondo K; Ishikura H; Maki H; Kinoshita H; Miyoshi T; Takahashi Y; Sawada N; Takizawa H; Nagao T; Sakiyama S; Monden Y
    Mol Cancer Ther; 2005 Sep; 4(9):1409-16. PubMed ID: 16170033
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Augmented growth inhibition of B16-BL6 melanoma by combined treatment with a selective matrix metalloproteinase inhibitor, MMI-166, and cytotoxic agents.
    Hojo K; Maki H; Sawada TY; Maekawa R; Yoshioka T
    Anticancer Res; 2002; 22(6A):3253-9. PubMed ID: 12530072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antitumor effect of a new selective matrix metalloproteinase inhibitor, MMI-166, on experimental pancreatic cancer.
    Matsushita A; Onda M; Uchida E; Maekawa R; Yoshioka T
    Int J Cancer; 2001 May; 92(3):434-40. PubMed ID: 11291083
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gabexate mesilate inhibits colon cancer growth, invasion, and metastasis by reducing matrix metalloproteinases and angiogenesis.
    Yoon WH; Jung YJ; Kim TD; Li G; Park BJ; Kim JY; Lee YC; Kim JM; Park JI; Park HD; No ZS; Lim K; Hwang BD; Kim YS
    Clin Cancer Res; 2004 Jul; 10(13):4517-26. PubMed ID: 15240544
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Matrix metalloproteinase inhibitor, marimastat, decreases peritoneal spread of gastric carcinoma in nude mice.
    Kimata M; Otani Y; Kubota T; Igarashi N; Yokoyama T; Wada N; Yoshimizu N; Fujii M; Kameyama K; Okada Y; Kumai K; Kitajima M
    Jpn J Cancer Res; 2002 Jul; 93(7):834-41. PubMed ID: 12149150
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of hepatic metastasis of human colon cancer by angiogenesis inhibitor TNP-470.
    Tanaka T; Konno H; Matsuda I; Nakamura S; Baba S
    Cancer Res; 1995 Feb; 55(4):836-9. PubMed ID: 7531615
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enhancement of antitumor activity of mitomycin C in vitro and in vivo by UCN-01, a selective inhibitor of protein kinase C.
    Akinaga S; Nomura K; Gomi K; Okabe M
    Cancer Chemother Pharmacol; 1993; 32(3):183-9. PubMed ID: 8500222
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Efficacy of an angiogenesis inhibitor, TNP-470, in xenotransplanted human colorectal cancer with high metastatic potential.
    Konno H; Tanaka T; Kanai T; Maruyama K; Nakamura S; Baba S
    Cancer; 1996 Apr; 77(8 Suppl):1736-40. PubMed ID: 8608571
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Inhibitory effect of angiogenesis inhibitor YH-16 on liver metastases from colorectal cancer].
    Zhou ZW; Wan DS; Wang GQ; Ren JQ; Lu ZH; Lin SX; Tang SX; Ye YL; Chen G
    Ai Zheng; 2006 Jul; 25(7):818-22. PubMed ID: 16831270
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MMI-166, a selective matrix metalloproteinase inhibitor, promotes apoptosis in human pancreatic cancer.
    Gao CC; Gong BG; Wu JB; Cheng PG; Xu HY; Song DK; Li F
    Med Oncol; 2015 Jan; 32(1):418. PubMed ID: 25471789
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice.
    Kato T; Sato K; Kakinuma H; Matsuda Y
    Cancer Res; 1994 Oct; 54(19):5143-7. PubMed ID: 7522956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.